Selected article for: "care department and intensive care"
Author: Waite, Alicia A. C.; Hamilton, David O.; Pizzi, Roberto; Ageno, Walter; Welters, Ingeborg D.
Title: Hypercoagulopathy in Severe COVID-19: Implications for Acute Care
  • Cord-id: 0d3zssof
  • Document date: 2020_12_23
    • ID: 0d3zssof
    Snippet: COVID-19 was first described in late 2019 and has since developed into a pandemic affecting more than 21 million people worldwide. Of particular relevance for acute care is the occurrence of COVID-19-associated coagulopathy (CAC), which is characterised by hypercoagulability, immunothrombosis and venous thromboembolism, and contributes to hypoxia in a significant proportion of patients. This review describes diagnosis and treatment of CAC in the emergency department and in intensive care. We sum
    Document: COVID-19 was first described in late 2019 and has since developed into a pandemic affecting more than 21 million people worldwide. Of particular relevance for acute care is the occurrence of COVID-19-associated coagulopathy (CAC), which is characterised by hypercoagulability, immunothrombosis and venous thromboembolism, and contributes to hypoxia in a significant proportion of patients. This review describes diagnosis and treatment of CAC in the emergency department and in intensive care. We summarise the pathological mechanisms and common complications of CAC such as pulmonary thrombosis and venous thromboembolic events and discuss current strategies for thromboprophylaxis and therapeutic anti-coagulation in the acute care setting.

    Search related documents:
    Co phrase search for related documents
    • absolute lymphocyte count and acute care: 1
    • absolute lymphocyte count and acute phase: 1
    • activ vaccines and acute lung injury: 1
    • activ vaccines therapeutic interventions and acute lung injury: 1
    • activation recruitment and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • activation recruitment and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • activation recruitment and acute phase: 1, 2, 3
    • activation recruitment and acute respiratory failure: 1, 2, 3
    • acute ards respiratory distress syndrome and adaptive design: 1
    • acute ards respiratory distress syndrome and adaptive phase: 1, 2
    • acute respiratory failure and adaptive design: 1